Antiviral Activities of Polysaccharides from Medicinal Herbs
Abstract:
For thousands of
years, medicinal herbs have been a cornerstone of clinical practice, offering a
wealth of health benefits. Among these benefits, the antiviral properties of
polysaccharides found in these herbs are now gaining recognition. This review
provides an in-depth exploration of the antiviral effects of these
polysaccharides on viruses affecting humans. It delves into how these
polysaccharides inhibit various stages of the viral life cycle, effectively
preventing viral infection. Furthermore, the review discusses additional
mechanisms through which these polysaccharides exert antiviral effects, such as
bolstering immune responses, regulating inflammatory reactions, maintaining gut
flora balance, reducing oxidative stress, and inhibiting apoptosis through
specific signaling pathways. The article also examines the structure-function
relationships of natural polysaccharides, providing critical insights into
their antiviral mechanisms and emphasizing the importance of further
comprehensive research and analysis. The review underscores the potential of
polysaccharides from medicinal herbs as compelling candidates for combatting
viral infections in both humans and animals.
References:
[1]. Wang, Y.,
Di, Y., Ye, J., Wei, W., 2021. Study on the Public Psychological States and its
Related Factors During The Outbreak of Coronavirus Disease 2019 (COVID-19) in Some
Regions of China. Psychology, Health & Medicine 26:13-22.
[2]. Patel,
M. K., Bergeri I., Bresee J. S., Cowling B. J., Crowcroft N. S., et al. 2021.
Evaluation of Post-Introduction COVID-19 Vaccine Effectiveness: Summary of
Interim Guidance of the World Health Organization. Vaccine 39:4013-24.
[3]. Cao, X.,
2020. COVID-19: Immunopathology and its Implications for therapy. Nature
Reviews Immunology 20:269-70.
[4]. Al-Hakeim,
H. K, Al-Rubaye, H. T, Al-Hadrawi, D. S., Almulla, A. F, Maes, M., 2023.
Long-COVID Post-Viral Chronic Fatigue and Affective Symptoms Are Associated
With Oxidative Damage, Lowered Antioxidant Defenses And Inflammation: A Proof
of Concept And Mechanism Study. Molecular Psychiatry 28:564-78.
[5]. Mukherjee,
P. K., Efferth, T., Das, B., Kar, A., Ghosh, S., et al. 2022. Role of Medicinal
Plants in Inhibiting SARS-CoV-2 and in the Management of Post-COVID-19 Complications.
Phytomedicine 98:153930.
[6]. Han, A.
X., de Jong, S. P., Russell, C. A., 2023. Co-Evolution of Immunity And Seasonal
Influenza Viruses. Nature Reviews Microbiology 21:805-17.
[7]. Peckham,
R., 2020. Viral Surveillance and the 1968 Hong Kong Flu Pandemic. Journal of
Global History 15:444-58.
[8]. Honigsbaum,
M., 2020. Revisiting the 1957 and 1968 Influenza Pandemics. The Lancet
395:1824-6.
[9]. Li, Z.,
Li, L., Zhou, H., Zeng, L., Chen, T., et al. 2017. Radix Isatidis
Polysaccharides Inhibit Influenza A Virus and Influenza A Virus-Induced
Inflammation via Suppression of Host TLR3 Signaling in vitro. Molecules
22:116.
[10]. Sun, Z.,
Yu, C., Wang, W., Yu, G., Zhang, T., et al. 2018. Aloe Polysaccharides Inhibit
Influenza A Virus Infection—A Promising Natural Anti-Flu Drug. Frontiers in
Microbiology 9:2338
[11]. Li, Z.,
Cui, B., Liu, X., Wang, L., Xian, Q., et al. 2020. Virucidal Activity And The
Antiviral Mechanism of Acidic Polysaccharides Against Enterovirus 71 Infection In
Vitro. Microbiology and Immunology 64:189-201.
[12]. Bardsley,
M., Morbey, R. A., Hughes, H. E., Beck, C. R., Watson, C. H, et al. 2023.
Epidemiology of Respiratory Syncytial Virus in Children Younger Than 5 Years In
England during the COVID-19 Pandemic, measured by Laboratory, Clinical, And
Syndromic Surveillance: A Retrospective Observational Study. The Lancet
Infectious Diseases 23:56-66.
[13]. Zhong,
X., Zhang, Y., Yuan, M., Xu, L., Luo, X., et al. 2024. Prunella Vulgaris
Polysaccharide Inhibits herpes simplex virus infection By Blocking TLR-Mediated
Nf-Κb Activation. Chinese Medicine 19:6.
[14]. Kim, M.,
Kim, S-R., Park, J., Mun, S-H., Kwak, M, et al. 2022. Structure and Antiviral
Activity of a Pectic Polysaccharide from the Root of Sanguisorba Officinalis
against Enterovirus 71 in vitro/vivo. Carbohydrate Polymers
281:119057.
[15]. Pu, X.,
Wang, H., Li, Y., Fan, W., Yu, S., 2013. Antiviral Activity Of Guiqi Polysaccharides
against Enterovirus 71 in vitro. Virologica Sinica 28:352-9.
[16]. Lin, P.,
Wang, Q., Wang, Q., Chen, J., He, L., et al. 2024. Evaluation of the Anti-Atherosclerotic
Effect for Allium Macrostemon Bge. Polysaccharides and Structural
Characterization of its Newly Active Fructan. Carbohydrate Polymers
340:122289.
[17]. Shen, Y.,
Wu, S., Song, M., Zhang, H., Zhao, H., et al. 2024. The Isolation, Structural
Characterization and Anti-Inflammatory Potentials of Neutral Polysaccharides
from the Roots of Isatis indigotica Fort. Molecules 29:2683.
[18]. Lortholarie,
M., Do Nascimento, J., Bonnard I., Catteau A., Le Guernic A., et al. Assessment
of the Viral Contamination of Fecal Origin Over a Wide Geographical Area Using
an Active Approach with Dreissena Polymorpha. Available at SSRN 4773740.
[19]. Ji, Y.,
Han, J., Moses, M., Wang, D., Wu, L., et al. 2024. The Antimicrobial Property of
JY-1, A Complex Mixture of Traditional Chinese Medicine, Is Linked To It Abilities
to Suppress Biofilm formation and Disrupt Membrane Permeability. Microbial
Pathogenesis 189:106573.
[20]. Liu, T.,
Zhang, M., Niu, H., Liu, J., Ruilian, M., et al. 2019. Astragalus Polysaccharide
from Astragalus Melittin Ameliorates Inflammation via Suppressing the Activation
of TLR-4/NF-κB p65 Signal Pathway and Protects Mice from CVB3-induced Virus
Myocarditis. International Journal of Biological Macromolecules 126:179-86.
[21]. Fatima,
R., Sharma, M., Prasher, P., Gupta, G., Singh, K., et al. 2023. Elucidating the
Antiviral Potential of Polysaccharides. EXCLI Journal 22:108.
[22]. Wang, C.,
Ruan, S., Gu, X., Zhu, B., 2018. Antiviral Activities of Radix Isatidis Polysaccharide
Against type II Herpes Simplex Virus In Vitro. Food Science and
Technology 38:180-3.
[23]. Ahmadi,
A., Zorofchian Moghadamtousi, S., Abubakar, S., Zandi, K., 2015. Antiviral Potential
of Algae Polysaccharides Isolated from Marine Sources: A Review. BioMed Research
International 2015:825203.
[24]. Lin, Z.,
Liao, W., Ren, J., 2016. Physicochemical Characterization of A Polysaccharide
Fraction from Platycladus Orientalis (L.) Franco and its Macrophage
Immunomodulatory and Anti-Hepatitis B Virus Activities. Journal of
Agricultural and Food Chemistry 64:5813-23.
[25]. Cheng,
D., Sun, L., Zou, S., Chen, J., Mao, H., et al. 2019. Antiviral Effects of
Houttuynia Cordata Polysaccharide extract on Murine Norovirus-1 (MNV-1)—A Human
Norovirus Surrogate. Molecules 24:1835.
[26]. Jin,
M-Y., Li, M-Y., Huang, R-M., Wu, X-Y., Sun, Y-M., Xu, Z-L., 2021. Structural Features
and Anti-inflammatory Properties of Pectic Polysaccharides: A Review. Trends
in Food Science & Technology 107:284-98.
[27]. Singh,
S, Murti, Y, Semwal, B., 2024. Antiviral Activity of Natural Herbs and their
Isolated Bioactive Compounds: A Review. Combinatorial Chemistry & High
Throughput Screening 27:2013-42.
[28]. 28 Claus-Desbonnet, H., Nikly, E., Nalbantova, V.,
Karcheva-Bahchevanska, D., Ivanova, S., et al. 2022. Polysaccharides and their Derivatives
as Potential Antiviral Molecules. Viruses 14:426.
[29]. Belongia,
E. A., Naleway, A. L., 2003. Smallpox Vaccine: The Good, the Bad, and the Ugly.
Clinical Medicine & Research 1:87-92.
[30]. Kausar,
S., Said Khan, F., Ishaq Mujeeb Ur Rehman, M., Akram, M., Riaz, M., et al.
2021. A Review: Mechanism of Action of Antiviral Drugs. International Journal
of Immunopathology and Pharmacology 35:20587384211002621.
[31]. Wang, J.,
Zhu, Q., Xing, X., Sun, D., 2024. A Mini-Review on the Common Antiviral Drug
Targets of Coronavirus. Microorganisms 12:600.
[32]. Sun, K.,
Fournier, M., Sundberg, A. K., Song, I. H., 2024. Maribavir: Mechanism of Action,
Clinical, and Translational Science. Clinical and Translational Science
17:e13696.
[33]. Du, R.,
Achi, J. G., Cui, Q., Rong, L., 2024. Paving New Roads Toward The Advancement
of Broad‐Spectrum Antiviral Agents. Journal of Medical Virology
96:e29369.
[34]. De
Clercq, E., 2004. Antiviral Drugs in Current Clinical Use. Journal of Clinical
Virology 30:115-33.
[35]. Fan, Q.,
Zhang, B., Ma, J., Zhang, S., 2020. Safety Profile of the Antiviral Drug
Remdesivir: An Update. Biomedicine & Pharmacotherapy 130:110532.
[36]. Gonçalves, B. C., Lopes Barbosa, M. G., Silva Olak, A. P., Belebecha Terezo, N., Nishi, L., et al. 2021. Antiviral Therapies: Advances and Perspectives. Fundamental & Clinical Pharmacology 35:305-20.
